Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
bioAffinity Technologies, Inc. ( (BIAF) ) just unveiled an update.
On December 19, 2025, bioAffinity Technologies, Inc. convened but immediately adjourned a special meeting of stockholders after failing to reach a quorum, as an insufficient number of common shares were present in person or by proxy to conduct business. The special meeting has been rescheduled to reconvene on January 19, 2026, with the November 4, 2025 record date and all voting proposals unchanged, and previously submitted proxies remaining valid unless stockholders choose to alter their votes through the available proxy voting channels.
The most recent analyst rating on (BIAF) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on bioAffinity Technologies, Inc. stock, see the BIAF Stock Forecast page.
Spark’s Take on BIAF Stock
According to Spark, TipRanks’ AI Analyst, BIAF is a Neutral.
bioAffinity Technologies, Inc. has a low overall stock score due to significant financial challenges and poor valuation metrics. However, positive corporate events, such as increased test volumes and new patents, provide some optimism for future growth. The technical analysis indicates a bearish trend, further weighing down the score.
To see Spark’s full report on BIAF stock, click here.
More about bioAffinity Technologies, Inc.
Average Trading Volume: 2,766,913
Technical Sentiment Signal: Sell
Current Market Cap: $5.8M
For detailed information about BIAF stock, go to TipRanks’ Stock Analysis page.